| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2017) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L04AC12 |
| UNII: | 6ZA31Y954Z |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Interleukin-17 receptor A antagonist | PubMed |
| Primary Target | |
|---|---|
| Interleukin 17 receptor A |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Psoriasis | 4 | D011565 | FDA |
| Psoriasis | 4 | D011565 | ClinicalTrials |
| Psoriasis | 4 | D011565 | ClinicalTrials |
| Arthritis, Psoriatic | 3 | D015535 | ClinicalTrials |
| Spondylitis, Ankylosing | 3 | D013167 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Hidradenitis Suppurativa | 2 | D017497 | ClinicalTrials |
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Scleroderma, Systemic | 1 | D012595 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1174395-19-7 |
| ChEMBL | CHEMBL1742996 |
| FDA SRS | 6ZA31Y954Z |
| Guide to Pharmacology | 7540 |
CONTENTS